Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Predictive Oncology Inc (NQ: POAI )

0.6902 -0.0272 (-3.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Predictive Oncology Inc

< Previous 1 2 3 4 5 6 7 8 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Alkaline Water Company Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Gainers Auddia Inc. (NASDAQ: AUUD) jumped 115% to $1.14 in pre-market trading after gaining more than 10% on Wednesday. 
Via Benzinga
Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers CXApp Inc. (NASDAQ: CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday. 
Via Benzinga
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Names Oncology Translational Research Leader to Scientific Advisory Board
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI), Integra Therapeutics Collaborate to Advance Gene Therapy
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Collaborates to Leverage AI for New Cancer Drugs, Announces 2022 Results
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Key Partnership, Declares Dividend
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Engages with Leading IR Consultant to Implement Comprehensive IR Effort
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner
Comprehensive, multi-faceted IR program to focus on raising awareness of Predictive Oncology and its portfolio of unique, proprietary assets capable of accelerating oncologic drug discovery and... 
From Predictive Oncology Inc.
Via GlobeNewswire
Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Updates Shareholders, Provides Company Overview and Plans for Future
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Issues Letter to Shareholders
From Predictive Oncology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO Talks New Cvergenx Partnership During Proactive Interview
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI), Cvergenx Inc. to Collaborate in Novel Approach to Personalized Radiotherapy and Drug Discovery
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Names New Chief Business Officer
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 AI Penny Stocks That Could Skyrocket in 2023
AI penny stocks represent great potential and high returns, given the fact this technology is only beginning to pervade society. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.